As I predicted a while ago that they would use feedback from partners rather than doing a proper clinical trial. Now they seem to do mix bag of getting informal feedback from unspecified medical centres an informal feedback from individual doctors who jump on early adopter plan under that special access scheme. There is nothing new about this announcement about the repeat that the capsules are available for ordering in 1st half of 2020. This language seems to set a deadline that by end of 1st half of 2020, the capsules should be on sale. So I expect that, in the next 4-5 months, they will announce, "The capsule is NOW available for order in special access scheme."
So, this announcement is pretty much old news.
I took a small dip just for fun, got in at 28c and should have sold at 33c but instead set a stop loss at 30.5c hoping it would go up higher. The shares ended up sold at 30.5c. Any way, it's not running away any time soon unless they announce that this capsule may help people avoid the coronavirusThe Chinese will snap it up and send back to China. But it's illegal to sell it outside the special access scheme and it's not available right now.
I would advise AusCann to start thinking about making cannabis hand sanitiser. It will really help to get some revenue going
- Forums
- ASX - By Stock
- AC8
- Ann: AusCann Releases Low-dose Form Capsule
Ann: AusCann Releases Low-dose Form Capsule, page-22
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AC8 (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $17.62M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AC8 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online